That makes no sense pure speculation on your part. There is nothing stated in the PR that EUA is not in the table or ready to be announced any day for that matter. We currently not only meet but exceed all guidelines for EUA. Leronlimab safety profile is like gold standard and this trail along with all the EIND’s and by now I’m sure some of the OLE warrant an immediate EUA and they can run the new protocol to increase the number of critical patents to have data on. I will be very surprised also if leronlimab doesn’t show a stop in progression from severe to critical, as well as Reduced hospital stay and discharge from hospital at day 28 better in the entire Severe Population.